John T. Callaghan

Also affiliated with Indiana University – Purdue University Indianapolis

Pharmacology, Toxicology and PharmaceuticsMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and HLA‐B Genotypes and Phenytoin Dosing: 2020 Update”.

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and HLA‐B Genotypes and Phenytoin Dosing: 2020 Update

Clinical Pharmacology & Therapeutics(2020)10.1002/cpt.2008

N/A

4.0DataRank · unranked

173 citations

Allan E. Rettie, Andrew A. Somogyi, Rachel Huddart, Alison E. Fohner, Christine M. Formea +10 more

Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid Therapy

Clinical Pharmacology & Therapeutics(2021)10.1002/cpt.2149

N/A

0.904DataRank · unranked

412 citations

Andrew A. Monte, Rachel Huddart, Kelly E. Caudle, Evan D. Kharasch, Andrea Gaedigk +16 more

The INGENIOUS trial: Impact of pharmacogenetic testing on adverse events in a pragmatic clinical trial

The Pharmacogenomics Journal(2023)10.1038/s41397-023-00315-w

N/A

0.416DataRank · unranked

15 citations

Marc B. Rosenman, Pengyue Zhang, Cathy R. Fulton, John T. Callaghan, Ann Holmes +16 more

Development of a Multifaceted Program for Pharmacogenetics Adoption at an Academic Medical Center: Practical Considerations and Lessons Learned

Clinical Pharmacology & Therapeutics(2024)10.1002/cpt.3402

N/A

0.416DataRank · unranked

15 citations

Emma M. Tillman, Amy M. Breman, Jennelle C. Hodge, C. McDonald, Reynold C. Ly +10 more

Return of Clinically Actionable Pharmacogenetic Results From Molecular Tumor Board DNA Sequencing Data: Workflow and Estimated Costs

Clinical Pharmacology & Therapeutics(2025)10.1002/cpt.3545

N/A

0.165DataRank · unranked

2 citations

Tayler B. Smith, John T. Callaghan, Wilberforce Osei, Steven M. Bray, Emma M. Tillman +6 more

Pharmacogenetics of steady-state metabolism, pharmacokinetics, and adverse effects of voriconazole in healthy participants

Drug Metabolism and Disposition(2025)10.1016/j.dmd.2025.100156

N/A

0DataRank · unranked

2 citations

Ayşe Gelal, Chisook Moon, Ingrid F. Metzger, Jessica Bo Li Lu, John T. Callaghan +3 more